Two Sigma Securities’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-262
Closed -$312K 2330
2019
Q3
$312K Buy
+262
New +$400K ﹤0.01% 1516
2019
Q2
Sell
-332
Closed -$677K 2086
2019
Q1
$677K Buy
+332
New +$585K 0.01% 738

Other funds holding BLUE

Two Sigma Securities's BLUE Position: Q1 2023 in Review

Two Sigma Securities sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 734 shares — an estimated $102K sold.

Two Sigma Securities first reported a position in BLUE in Q1 2017 and held it in 6 quarters. The position peaked at $1.32M in Q2 2017. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Two Sigma Securities reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Securities sold 734 bluebird bio shares in Q1 2023, an estimated $102K.
  • Two Sigma Securities first reported a position in bluebird bio in Q1 2017 and held it in 6 quarters.
  • Two Sigma Securities's bluebird bio position peaked at $1.32M in Q2 2017.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.